PROK2 and neoplasm: In addition, activated MDSCs in tumours could affect tumour remodelling and tumour angiogenesis by producing VEGF, basic fibroblast growth factor (bFGF), Bv8 and MMP9, thereby promoting tumour progression [17, 18].